An actuarial model of arrhythmogenic right ventricular cardiomyopathy and life insurance

DOI10.1080/03461238.2021.1930136zbMATH Open1491.91108OpenAlexW3165866958MaRDI QIDQ5083402FDOQ5083402

Authors: Oytun Haçarız, Torsten Kleinow, Angus S. Macdonald 

Publication date: 20 June 2022

Published in: Scandinavian Actuarial Journal (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/03461238.2021.1930136

Recommendations

• Genetics, insurance and hypertrophic cardiomyopathy
• Effective Underwriting in the Genetic Testing Era
• The genetics of breast and ovarian cancer. V: Application to income protection insurance
• A Model for Coronary Heart Disease and Stroke with Applications to Critical Illness Insurance Underwriting II: Applications
• A Model for Coronary Heart Disease and Stroke with Applications to Critical Illness Insurance Underwriting I: The Model

zbMATH Keywords

genetic epidemiologyadverse selectionlife insurancecascade genetic testingarrhythmogenic right ventricular cardiomyopathy

Mathematics Subject Classification ID

Actuarial mathematics (91G05) Epidemiology (92D30) Genetics and epigenetics (92D10)

Cites Work

• Genetics, insurance and hypertrophic cardiomyopathy

Cited In (1)

• Effective Underwriting in the Genetic Testing Era

This page was built for publication: An actuarial model of arrhythmogenic right ventricular cardiomyopathy and life insurance

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5083402)